Research Digest

Research Digest 21/02/20

Welcome to the 41st edition, featuring a Doppler study that confirms a reduction in cerebral blood flow in ME/CFS patients & an Australian study that looks at the levels of parasympathetic activity during sleep. Read more

Research Digest 07/02/20

Welcome to the 40th edition, featuring an American metabolomics study of patient plasma and a study looking at the prevalence of paediatric ME/CFS in Chicago according to diverse community-based random sample. Read more

Research Digest 24/01/20

Welcome to the 39th edition, featuring a systematic review of ME/CFS randomized controlled trials and a study into the use of heart rate variability as a non-invasive biomarker for predicting fatigue severity in ME/CFS patients. Read more

Research Digest 10/01/20

Welcome to the 38th edition, featuring a Nature paper examining blood lactate levels in ME/CFS patients whilst at rest and a paper investigating the effect of pharmaceutical intervention on NK cell cytotoxicity in ME/CFS patients compared to healthy individuals. Read more

Research Digest 13/12/19

Welcome to the 37th edition, featuring a retrospective study on the effectiveness of using low-dose naltrexone on ME/CFS patients, and a meta-analysis comparing protein biomarkers of inflammation between ME/CFS patients and non-affected controls. Read more

Research Digest 29/11/19

Welcome to the 36th edition, featuring research looking at altered cardiac autonomic regulation in ME/CFS patients, an analysis of risk factors for ME/CFS and a systematic review of natural killer cells and cytotoxic function in ME/CFS. Read more

Research Digest 15/11/19

Welcome to the 35th edition, featuring an article that examines the results of the controversial PACE trial and offers an alternative clinical approach for practitioners working with patients with ME/CFS, and a paper from NCNED suggesting a potential pharmaco-therapeutic intervention for ME/CFS. Read more

Research Digest 1/11/19

Welcome to the 34th edition, featuring an editorial on the advances in ME/CFS research and clinical care, and a Cochrane amended review of the effectiveness of graded exercise therapy. Read more

Cochrane has released an update of its review of graded exercise therapy (GET) for ME/CFS

The 2017 Cochrane review of exercise therapy was the subject of a serious complaint which highlighted flaws in its methodology and the methodology of the studies which it reviewed. Cochrane has been working with the review authors to deal with the complaint for over a year. It has now published an update of the review. Read more

Latest

Telehealth Services – COVID-19 and at-risk groups

The Federal Government has announced funding for new health measures under the Medicare Benefits Schedule (MBS), including telehealth services to minimise community transmission of COVID-19.

Coronavirus and ME - Simplified facts

Many people with ME/CFS and other vulnerable communities in Australia are concerned about the impacts of the spreading coronavirus disease COVID-19. This is an easy-read resource with the latest information and advice.

Government to fund telehealth services in response to Coronavirus

The Prime Minister has announced that the government will fund new health measures under Medicare, including telehealth services and online prescriptions.

Coronavirus and ME

We know that many people with ME/CFS (as well as those caring for them) are experiencing concern about the spread of, and possibly contracting, coronavirus. We recognise that people with chronic illness have valid reasons for additional caution at this time.